Countering severe peanut allergies through oral immunotherapy

Image credit: ThinkStock

Mom Monica Glover said the family discovered Ellis’ peanut allergy when she was about 3.

Glover seized the opportunity to participate in a study on the safety and effectiveness of an experimental treatment that could give her daughter protection against accidental exposure to peanuts. Despite the risk, it was “a gift,” she said, adding that her family hoped their efforts might help “lots of other children.”

The risk paid off: Two-thirds of the kids in the study were able to eat the equivalent of two peanuts without any symptoms after following the months-long experimental treatment regimen, the researchers found.


The treatment, which comes in powder-filled capsules, is an oral immunotherapy, and the concept is “treating an allergy by gradually exposing people to the very same thing they’re allergic to,” [researcher Brian] Vickery said. Essentially, the treatment is a peanut powder.

Related article:  Not all children are safe from COVID-19: Mysterious childhood illness similar to Kawasaki disease linked to coronavirus

“It’s what a lot of families call trying to be ‘bite safe.’ it’s not that you’re curing the allergy; it’s not that you’re going to be able to eat peanut butter sandwiches,” said [pediatrician Scott] Sicherer, who was not involved in the study. “It’s really just to have a better threshold so that if you accidentally ate something that had a little bit of peanut in it, maybe you wouldn’t have a reaction or the reaction wouldn’t be so bad.”


Read full, original post: Experimental treatment helps 2 out of 3 peanut allergy sufferers, study finds

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend